State Street’s Biolase, Inc. BIOL Stock Holding History

State Street’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-174	Closed	-$1.23K	–	4620
2023 Q2	$1.23K	Hold	174	–	–	﹤0.01%	4671
2023 Q1	$4.9K	Hold	174	–	–	﹤0.01%	4769
2022 Q4	$11.3K	Hold	174	–	–	﹤0.01%	4793
2022 Q3	$42K	Hold	174	–	–	﹤0.01%	4692
2022 Q2	$80K	Hold	174	–	–	﹤0.01%	4607
2022 Q1	$154K	Buy	174 +7	+4%	+$6.46K	﹤0.01%	4479
2021 Q4	$163K	Hold	167	–	–	﹤0.01%	4428
2021 Q3	$267K	Sell	167 -49	-23%	-$80K	﹤0.01%	4246
2021 Q2	$378K	Buy	216 +211	+4,220%	+$392K	﹤0.01%	3965
2021 Q1	$10K	Buy	+5	New	+$12.3K	﹤0.01%	3973
2018 Q2	–	Sell	-2	Closed	-$10K	–	3811
2018 Q1	$10K	Hold	2	–	–	﹤0.01%	3739
2017 Q4	$10K	Buy	2 +1	+100%	+$7.03K	﹤0.01%	3714
2017 Q3	$11K	Hold	1	–	–	﹤0.01%	3743
2017 Q2	$17K	Hold	1	–	–	﹤0.01%	3660
2017 Q1	$24K	Hold	1	–	–	﹤0.01%	3609
2016 Q4	$26K	Hold	1	–	–	﹤0.01%	3597
2016 Q3	$31K	Hold	1	–	–	﹤0.01%	3509
2016 Q2	$22K	Hold	1	–	–	﹤0.01%	3650
2016 Q1	$24K	Hold	1	–	–	﹤0.01%	3659
2015 Q4	$15K	Hold	1	–	–	﹤0.01%	3669
2015 Q3	$16K	Hold	1	–	–	﹤0.01%	3675
2015 Q2	$31K	Sell	1 -1	-50%	-$24.4K	﹤0.01%	3639
2015 Q1	$39K	Hold	2	–	–	﹤0.01%	3596
2014 Q4	$51K	Hold	2	–	–	﹤0.01%	3587
2014 Q3	$51K	Hold	2	–	–	﹤0.01%	3569
2014 Q2	$46K	Sell	2 -32	-94%	-$817K	﹤0.01%	3551
2014 Q1	$1.01M	Buy	34 +15	+79%	+$523K	﹤0.01%	3255
2013 Q4	$668K	Buy	19 +1	+6%	+$23.7K	﹤0.01%	3317
2013 Q3	$435K	Buy	18 +13	+260%	+$419K	﹤0.01%	3364
2013 Q2	$223K	Buy	+5	New	+$280K	﹤0.01%	3325

Other funds holding BIOL

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street's BIOL Position: Q3 2023 in Review

State Street sold out of Biolase, Inc. (BIOL) in Q3 2023, closing a stake of 174 shares — an estimated $1.23K sold.

State Street first reported a position in BIOL in Q2 2013 and held it in 30 quarters. The position peaked at $1.01M in Q1 2014. 12 funds tracked by Wall St. Rank hold BIOL as of Q3 2023.

State Street reported no remaining Biolase, Inc. position as of Q3 2023 after selling out during the quarter.
State Street sold 174 Biolase, Inc. shares in Q3 2023, an estimated $1.23K.
State Street first reported a position in Biolase, Inc. in Q2 2013 and held it in 30 quarters.
State Street's Biolase, Inc. position peaked at $1.01M in Q1 2014.
12 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.